New Delhi | Feb 10, 2011
With finances drying up for research projects as the world economy has slumped, the International AIDS Vaccine Initiative (IAVI) has sought more funds for work on developing prevention vaccines. The issue needs to be given priority at the moment because there are several encouraging developments happening globally in the field of AIDS vaccine research and we are closer to results,” Seth Berkeley, CEO, IAVI, said. The IAVI is working on several research projects in India including with the Department of Biotechnology, the Indian Institute of Science, the National Aids Research Institute, the AIIMS and the PGI Chandigarh, to name a few. Pointing out that pricing of the possible vaccine in the near future was a critical issue, Dr Berkeley said it would be meant for the target groups initially, and not as a public health intervention.
Health News Update